Results 141 to 150 of about 21,951 (195)

Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study. [PDF]

Haematologica
Shu M, Ding W, Wang L, Wang Z, Wang L, Zhu M, Liu D, Shen H, Wang Y, Dou X, Ma X, Zhang Y, Xu Y, Wang Y, Xue S, Fu J, Qiu H, Tang X, Han Y, Huang J, Wu D, Dai H, Wen L, Chen S.   +23 more
europepmc   +1 more source

Digital and Paper-Based Hospital Workflows and 60-Day Mortality in Acute Leukemia: Retrospective Natural Experiment. [PDF]

JMIR Cancer
Ramos Peñafiel CO, Cabrera García Á, Balderas Delgado C, Luna Tentle R, Milán Salvatierra A, Godínez Cubillo N, Acosta Altamirano G, Sánchez Conejo R, Gallardo Rodríguez AG.   +8 more
europepmc   +1 more source

Acute Promyelocytic Leukemia Presenting as Spontaneous Abortion Amidst Tropical Fever Season: A Diagnostic Challenge. [PDF]

Cureus
Rathod A, Gupta M, Palta A.
europepmc   +1 more source

Beyond Bleeding: Underrecognized Thrombotic Complications in Acute Promyelocytic Leukemia - A Single-Center Experience from the GCC Region. [PDF]

Clin Appl Thromb Hemost
Mohamed SF, AlShebly R, Shawaylia H, Elahie A, Ghasoub R, Soliman D, Mudawi D, Abdulgayoom M, Al-Mashdali AF, Rabadi M, El-Sabah H, Hamad A, Yassin M, Cherif H.   +13 more
europepmc   +1 more source

Severe Gout During Arsenic Therapy: Insights on Oxidative Stress and Interleukin-1β in Gout. [PDF]

ACR Open Rheumatol
Hamilton J, Alexander A.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Acute Promyelocytic Leukemia

Journal of Pediatric Hematology/Oncology, 1995
Significant advances have occurred in the diagnosis, treatment, and long-term outcome of patients with acute promyelocytic leukemia (APL). The purpose of this review is to describe the molecular genetics of this disease, the use of all-trans retinoic acid (ATRA) in clinical trials of APL, and the clinical and basic research questions for future ...
R S, Lemons, S, Keller, D, Gietzen, J, Dufner, M, Rebentisch, J, Feusner, D, Eilender   +6 more
openaire   +2 more sources

Acute promyelocytic leukemia

American Journal of Hematology, 1979
AbstractAcute promyelocytic leukemia (APL) is characterized by proliferation of morphologically abnormal promyelocytes and a severe bleeding diathesis. The abnormal promyelocyte is characterized by abundant, large granules, many of which are spindle‐shaped. Electron microscopic appearance of the granules closely resembles that of Auer rods.
J, Groopman, L, Ellman
openaire   +2 more sources

Acute Promyelocytic Leukemia

New England Journal of Medicine, 1993
Perhaps the most important advance in this field is not the specific actions of all-trans-retinoic acid in acute promyelocytic leukemia, but rather the conclusive documentation of differentiation as a practical and consistently effective method of treating human cancer. As a drug, all-trans-retinoic acid has certain undesirable pharmacologic properties
R P, Warrell, H, de Thé, Z Y, Wang, L, Degos   +3 more
openaire   +2 more sources

Thrombosis in acute promyelocytic leukemia

Thrombosis Research, 2013
Compared to bleeding, major thromboses are a less commonly encountered problem in acute promyelocytic leukemia (APL), and our knowledge about the epidemiology of major thromboses in APL stems mainly from individual case reports. The purpose of this study was to provide a better understanding of the epidemiology of APL-related thrombosis as a first step
Armin, Rashidi, Marc L, Silverberg, Paul R, Conkling, Stephen I, Fisher   +3 more
openaire   +2 more sources